No benefit of plasma therapy in reducing Covid-19 mortality risk, says AIIMS trial interim analysis

Convalescent plasma therapy did not show benefit in reducing mortality risk among Covid-19 patients, according to an interim analysis of a randomised controlled trial done at AIIMS here to assess the efficacy of this mode of treatment.